UBS Maintains Neutral on RXO, Raises Price Target to $30.25
Susquehanna Maintains Neutral on RXO, Raises Price Target to $30
RXO, Inc. Reports Third-Quarter 2026 Revenue of $1.9 Billion and Pending Acquisition by C.H. Robinson
RXO (NYSE:RXO) exceeds Q3 2026 expectations
RXO (RXO) Reports Q3 Earnings: What Key Metrics Have to Say
RXO: Q3 Earnings Snapshot
RXO Q3 Adj. EPS $0.09 Beats $0.07 Estimate, Sales $1.871B Beat $1.808B Estimate
RXO Consensus Price Target Increased by 10.06% to $28.45
Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock
RXO Named Top Company for Women to Work in Trucking
3 Reasons to Avoid RXO and 1 Stock to Buy Instead
Truist Securities Maintains Buy on RXO, Raises Price Target to $30
JP Morgan Upgrades RXO to Neutral from Underweight
TD Cowen Upgrades RXO to Hold from Sell
C.H. Robinson: RXO Is No Shortcut To Value, I Say 'No'
C.H. Robinson's RXO Acquisition to 'Meaningfully' Widen Gap With Competitors, UBS Securities Says
Citigroup Maintains Neutral on RXO, Raises Price Target to $30
RXO (RXO) Is Attractively Priced Despite Fast-paced Momentum
TD Cowen Upgrades RXO to Hold, Raises Price Target to $30.25
Wells Fargo Maintains Equal-Weight on RXO, Raises Price Target to $30
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.